Kling AI, the AI-powered creative platform, today announced the launch of its Kling 3.0 models — including Video 3.0, Video 3.0 Omni, Image 3.0 and Image 3.0 Omni — giving
A shift is underway in the global film industry as creators across the globe embrace Kling AI to produce cinematic-level visuals and push the boundaries of storytelling. At the Marche
On June 11, the Grand Ceremony Honoring Emperor Yan, also known as Shennong, was held in Suizhou, Hubei Province, the legendary birthplace of the Chinese ancestor. Nearly 3,000 representatives from
The Key CAR T-Cell Therapy for Non-Hodgkin’s lymphoma Companies in the market include – Gilead Sciences (Kite Pharma), Novartis, BMS, Allogene Therapeutics, Novartis, Hrain Biotechnology, Lazaros Lekakis, Beijing Immunochina Medical
The Key Diabetic Retinopathy Companies in the market include – Genentech, Ionis Pharmaceuticals, AstraZeneca, Regenxbio, AbbVie, Palatin Technologies, Avirmax Biopharma, Ocular Therapeutix, Inc., MingSight Pharmaceuticals, Inc, OcuTerra Therapeutics, Inc., RemeGen
Key membranous nephropathy companies such as Roche, BeOne Medicines, Biogen, Vertex Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Climb Bio, and others are driving innovation and growth in the global membranous nephropathy market.
AIVA, an AI-native mobility brand, was officially unveiled in Beijing on 9 June 2026. AIVA will collaborate with Volcano Engine, ByteDance’s cloud and AI platform, to jointly define, design, and
The market dynamics for Focal Segmental Glomerulosclerosis (FSGS) are anticipated to witness notable growth driven by increasing disease awareness, rising diagnosis rates, growing understanding of genetic and podocyte-related disease mechanisms,
Amid the booming global expansion of industrial automation, automotive electronics, and energy storage industries, the demand for high-stability, durable, and fully sealed connection components continues to surge worldwide. To meet
DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. Key Takeaways from the Opioid
With the rapid development of global power distribution, switchgear manufacturing intelligent, high-precision and cost-efficient production equipment has become an indispensable part of modern electrical manufacturing. As a professional enterprise focusing
Emerging Juvenile Idiopathic Arthritis Therapies include Upadacitinib (RINVOQ), Sarilumab (KEVZARA), Deucravacitinib (SOTYKTU), Abatacept (ORENCIA), Bimekizumab (BIMZELX), MAS825, Filgotinib (JYSELECA), and others. DelveInsight’s Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market
Amid the global booming circular economy and accelerating scrap metal resource recycling, Jiangsu Huanhong Hydraulic Co., Ltd., a leading professional hydraulic equipment manufacturer based in Jiangyin City, Jiangsu Province, has
The idea of “Dad Style” has evolved. Summer 2026 menswear is less about trends and more about effortless versatility — lightweight fabrics, relaxed fits, and pieces that move easily from
Driven by demographic changes and upgrading consumption awareness, the global disposable hygiene industry maintains stable expansion. According to industry statistical data, the global hygiene product market size exceeded USD 270
DelveInsight’s “Sepsis Pipeline Insight 2026” report provides comprehensive insights about 28+ companies and 30+ pipeline drugs in the Sepsis pipeline landscape. It covers the Sepsis pipeline drug profiles, including clinical
DelveInsight’s ” Leptomeningeal Metastases Market Insights, Epidemiology, and Market Forecast – 2034″ report delivers an in-depth understanding of Leptomeningeal Metastases, historical and forecasted epidemiology, as well as the Leptomeningeal Metastases
DelveInsight’s, “Brain Metastases Pipeline Insights 2026” report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline
DelveInsight’s, “Postoperative Pain Pipeline Insight, 2026” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Postoperative Pain pipeline landscape. It covers the pipeline drug profiles, including clinical
DelveInsight’s, “Osteoporosis Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical
